NasdaqCM - Nasdaq Real Time Price USD

BioNexus Gene Lab Corp. (BGLC)

Compare
0.3000 0.0000 (0.00%)
As of 9:59 AM EST. Market Open.
Loading Chart for BGLC
DELL
  • Previous Close 0.3000
  • Open 0.3000
  • Bid 0.2030 x 200
  • Ask 0.3900 x 200
  • Day's Range 0.3000 - 0.3000
  • 52 Week Range 0.2810 - 3.3900
  • Volume 12,952
  • Avg. Volume 386,057
  • Market Cap (intraday) 5.39M
  • Beta (5Y Monthly) 1.87
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

www.bionexusgenelab.com

30

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BGLC

View More

Performance Overview: BGLC

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BGLC
43.40%
S&P 500
24.07%

1-Year Return

BGLC
22.48%
S&P 500
30.14%

3-Year Return

BGLC
84.46%
S&P 500
25.97%

5-Year Return

BGLC
86.36%
S&P 500
54.73%

Compare To: BGLC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BGLC

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    5.39M

  • Enterprise Value

    1.48M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    0.57

  • Enterprise Value/Revenue

    0.16

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -24.01%

  • Return on Assets (ttm)

    -10.11%

  • Return on Equity (ttm)

    -28.44%

  • Revenue (ttm)

    9.18M

  • Net Income Avi to Common (ttm)

    -2.21M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.41M

  • Total Debt/Equity (mrq)

    4.73%

  • Levered Free Cash Flow (ttm)

    -190.55k

Research Analysis: BGLC

View More

Company Insights: BGLC

Research Reports: BGLC

View More

People Also Watch